ghk-cu copper content mg per mg peptide – Research GHK-Cu Copper Peptide Hair &

171,172 In an older randomized placebo-controlled trial in 45 women with fibromyalgia and low levels of IGF-1 (a peptide made in the liver in response to stimulation by growth hormone), those receiving subcutaneous growth hormone injections for nine months had greater reductions in tender points and fibromyalgia impact scores and were more likely to experience global improvement compared with those receiving placebo

Human studies demonstrate sustained, dose-dependent increases in both GH and IGF-1 with subcutaneous administration [1]

GHK-Cu Regulatory Status GHK-Cu is not an FDA-approved drug

The compound then received GRAS (Generally Recognized as Safe) designation from the FDA for use as a food ingredient, which is a separate regulatory category from drug approval